Meta-analysis reveals a dose-response relationship, indicating higher noradrenaline increases mortality risk in critically ill patients.
In critically ill patients, escalating doses of noradrenaline correlate with an exponentially rising relative risk of mortality. This dose-dependent pattern reinforces the role of noradrenaline dose as a marker of cardiovascular failure severity.
No takes yet. Share an insight, caveat, or question.
Reinikainen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: